Anti-PD-1 Antibody(Jiangxi Provincial Cancer Hospital)

N/A

Report date: 2024/03/12 20:00:43

Base Information

Drug NameAnti-PD-1 Antibody(Jiangxi Provincial Cancer Hospital)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-PD-1
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsNasopharyngeal Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangxi Provincial Cancer Hospital
China Registration ClassN/A

Develop Information

Active CompaniesJiangxi Provincial Cancer Hospital
Inactive CompaniesN/A
Active IndicationsNasopharyngeal Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A